InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,185.01
(
-0.05%
)
US TECH 100
17,596.40
(
-0.09%
)
Dow Jones
39,027.83
(
0.37%
)
Brent Oil
83.52
(
0.78%
)
Bitcoin
62,382.57
(
0.08%
)
Post# of 8365
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

WallStreetSTTA

Send PM Follow Ignore
Followers 144
Posts 9913
Boards Moderated 0
Alias Born 06/22/2009

WallStreetSTTA

Re: None

Wednesday, 01/11/2017 10:27:48 AM

Wednesday, January 11, 2017 10:27:48 AM

Post# of 8365
There are two phase 3 trials busy right now:
1st trial is a 24 week combination therapy (140 in combo with HAART) which is done with 30 patients which started October 2015. The endpoint is Q1 2017 and the BLA will also be submitted in 2017.
The 2nd trial is a 48 week mono therapy which has 300 patients and started enrollment December 2016.

MUST READ CLICK
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127507128

SYM:CYDY
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up